F. Collet, B. Song, F. Rudolphi, L. J. Gooßen
FULL PAPER
77 (17). IR (KBr): ν = 1605 (s), 1549 (m), 1507 (vs), 1441 (m), 1338
N-[(4-acetylphenyl)(phenyl)methylene]-NЈ,NЈ-dimethyl-p-phenyl-
enediamine (4aag): Compound 4aag was synthesized according to
the general procedure described above from 5a (368 mg,
1.20 mmol) and 1-bromo-4-chlorobenzene (3g) (199 mg,
1.00 mmol). After purification by column chromatography (hex-
ane/ethyl acetate, 80:20), 4aag (195 mg, 57%) was obtained as a
reddish brown solid (m.p. 111 °C). 1H NMR [400 MHz, CDCl3,
two sets of signals for (E) and (Z) isomers, ratio approx. 1.1:1]: δ
= 7.89–7.99 (m, 2 H), 7.67–7.74 and 7.80–7.85 (2 m, 2 H), 7.27–
7.47 (m, 4 H), 7.15–7.19 (m, 1 H), 6.66–7.76 (m, 2 H), 6.52–6.58
(m, 2 H), 2.90 and 2.91 (2 s, 6 H), 2.62 and 2.65 (2 s, 3 H) ppm.
13C NMR [101 MHz, CDCl3, two sets of signals for (E) and (Z)
isomers]: δ = 197.6 and 197.8, 164.2 and 164.7, 147.5 and 147.7,
144.7, 142.3, 140.1, 140.0, 139.8, 137.8, 136.8, 136.5, 130.4, 129.9,
129.4, 129.0, 128.8, 128.6, 128.4, 128.2, 128.1, 128.0, 123.1 and
123.6, 112.4 and 112.6, 40.6 and 40.7, 26.6 and 26.8 ppm.
˜
(m), 1226 (m), 1164 (m), 1122 (m), 1090 (s), 958 (m), 820 (vs), 702
(vs), 670 (w) cm–1.
N-[{4-(Dimethylamino)phenyl}(phenyl)methylene]-NЈ,NЈ-dimethyl-
p-phenylenediamine (4aad): Compound 4aad was synthesized ac-
cording to the general procedure described above from 5a (368 mg,
1.20 mmol) and 2-bromo-N,N-dimethylaniline (3d) (200 mg,
1.00 mmol). After purification by column chromatography (hex-
ane/ethyl acetate, 80:20), 4aad (170 mg, 50%) was obtained as an
1
orange solid (m.p. 173 °C). H NMR [400 MHz, CDCl3, two sets
of signals for (E) and (Z) isomers, ratio approx. 2.1:1]: δ = 7.61–
7.69 and 7.71–7.76 (2 m, 2 H), 7.26–7.34 and 7.36–7.47 (2 m, 3 H),
7.03–7.10 and 7.16–7.23 (2 m, 2 H), 6.52–6.84 (m, 6 H), 2.99 and
3.04 (2 s, 6 H), 2.87 and 2.91 (2 s, 6 H) ppm. 13C NMR [101 MHz,
CDCl3, two sets of signals for (E) and (Z) isomers]: δ = 166.1 and
166.7, 151.7, 150.1, 146.8 and 147.0, 142.1, 141.8, 141.6, 137.8,
131.5, 130.4, 129.7, 129.6, 129.4, 128.2, 127.9, 127.8, 124.0, 123.1,
122.9, 112.9 and 113.1, 111.0 and 111.1, 41.0, 40.1 and 40.2 ppm.
HRMS (EI): calcd. for C23H25N3 [M]+ 343.2048; found 343.2051.
MS (70 eV): m/z (%) = 344 (31), 343 (100) [M]+, 342 (21), 328 (12),
C
23H22N2O (342.44): calcd. C 80.67, H 6.48, N 8.18; found C
80.19, H 6.55, N 8.65. HRMS (EI): calcd. for C23H22N2O [M]+
342.1732; found 342.1720. MS (70 eV): m/z (%) = 344 (35), 343
(100) [M]+, 342 (19), 282 (19), 266 (23), 224 (24), 208 (35). IR
(KBr): ν = 1683 (vs), 1607 (vs), 1511 (vs), 1443 (m), 1399 (m), 1355
˜
266 (19), 208 (22), 77 (15). IR (KBr): ν = 1617 (m), 1583 (s), 1507
˜
(s), 1264 (vs), 1230 (s), 1184 (m), 1062 (m), 954 (m), 822 (s), 708
(s), 1441 (m), 1369 (m), 1343 (m), 1320 (m), 1224 (s), 1198 (m),
1164 (m), 1142 (m), 1058 (m), 942 (m), 914 (w), 816 (vs), 700 (s),
670 (m) cm–1.
(vs), 670 (m), 604 (w), 592 (w) cm–1.
N-[(4-Cyanophenyl)(phenyl)methylene]-NЈ,NЈ-dimethyl-p-phenyl-
enediamine (4aah): Compound 4aah was synthesized according to
the general procedure described above from 5a (368 mg,
1.20 mmol) and 4-bromobenzonitrile (3h) (182 mg, 110 μL,
1.00 mmol). After purification by column chromatography (hex-
ane/ethyl acetate, 80:20), 4aah (250 mg, 77%) was obtained as a red
solid (m.p. 148 °C). 1H NMR [400 MHz, CDCl3, two sets of signals
for (E) and (Z) isomers]: δ = 7.61–7.65 and 7.82–7.87 (2 m, 2 H),
7.65–7.70 (m, 2 H), 7.35–7.49 (m, 3 H), 7.14–7.19 and 7.27–7.33 (2
m, 2 H), 6.63–6.68 and 6.71–6.76 (2 m, 2 H), 6.52–6.58 (m, 2 H),
2.92 (s, 6 H) ppm. 13C NMR [101 MHz, CDCl3, two sets of signals
for (E) and (Z) isomers]: δ = 162.9 and 163.6, 147.7 and 148.0,
144.6, 142.2, 139.7, 139.4, 139.3, 136.4, 132.0, 131.8, 130.6, 130.3,
129.3, 129.2, 128.7, 128.6, 128.3, 123.8, 123.1, 118.8, 118.4, 113.0,
112.5, 112.2, 112.0. 40.56 and 40.62 ppm. C22H19N3 (325.41):
calcd. C 81.20, H 5.89, N 12.91; found C 81.24, H 5.85, N 12.97.
MS (70 eV): m/z (%) = 327 (35), 326 (100), 325 (12) [M]+, 249 (16),
N-[(2-Methoxyphenyl)(phenyl)methylene]-NЈ,NЈ-dimethyl-p-phen-
ylenediamine (4aae): Compound 4aae was synthesized according to
the general procedure described above from 5a (368 mg,
1.20 mmol) and 2-bromoanisole (3e) (187 mg, 125 μL, 1.00 mmol).
After purification by column chromatography (hexane/ethyl acet-
ate, 80:20), 4aae (190 mg, 58%) was obtained as an orange solid
(m.p. 93 °C). 1H NMR (400 MHz, CDCl3): δ = 7.72–7.77 (m, 2 H),
7.26–7.41 (m, 4 H), 6.97–7.02 (m, 1 H), 6.83–6.92 (m, 2 H), 6.71–
6.76 (m, 2 H), 6.51–6.57 (m, 2 H), 3.59 (s, 3 H), 2.84 (s, 6 H) ppm.
13C NMR (101 MHz, CDCl3): δ = 163.8, 156.9, 147.4, 141.3, 140.0,
130.0, 129.9, 129.6, 128.2, 126.7, 122.2, 120.4, 112.5, 110.9, 55.3,
40.9 ppm. C22H22N2O (330.43): calcd. C 79.97, H 6.71, N 8.48;
found C 80.05, H 6.69, N 8.49. MS (70 eV): m/z (%) = 331 (25),
330 (97) [M]+, 167 (21), 136 (100), 135 (69), 121 (23), 77 (25). IR
(KBr): ν = 1605 (s), 1509 (vs), 1485 (s), 1443 (s), 1345 (m), 1248
˜
(s), 1228 (s), 1166 (m), 1108 (m), 1046 (w), 1022 (m), 956 (m), 816
224 (34), 208 (18), 77 (26), 51 (14). IR (KBr): ν = 2227 (m), 1609
˜
(m), 754 (s), 698 (s) cm–1.
(s), 1513 (vs), 1443 (s), 1359 (s), 1318 (m), 1284 (w), 1230 (m), 1170
(m), 1066 (w), 950 (m), 814 (s), 782 (m), 698 (s) cm–1.
N,N-Dimethyl-NЈ-[(2-naphthyl)(phenyl)methylene]-p-phenylenedi-
amine (4aaf): Compound 4aaf was synthesized according to the
general procedure described above from 5a (368 mg, 1.20 mmol)
and 2-bromonaphthalene (3f) (207 mg, 1.00 mmol). After purifica-
tion by column chromatography (hexane/ethyl acetate, 85:15), 4aaf
N-[{4-(Ethoxycarbonyl)phenyl}(phenyl)methylene]-NЈ,NЈ-dimethyl-
p-phenylenediamine (4aai): Compound 4aai was synthesized ac-
cording to the general procedure described above from 5a (368 mg,
1.20 mmol) and ethyl 4-bromobenzoate (3i) (229 mg, 160 μL,
1.00 mmol). After purification by column chromatography (hex-
ane/ethyl acetate, 80:20), 4aai (260 mg, 70%) was obtained as a red
1
(185 mg, 53%) was obtained as an orange solid (m.p. 119 °C). H
NMR [400 MHz, CDCl3, two sets of signals for (E) and (Z) iso-
mers, ratio approx. 1.2:1]: δ = 7.99–8.02 and 8.11–8.15 (2 m, 1 H),
7.35–7.56 and 7.71–7.93 (2 m, 5 H), 6.73–6.82 and 7.23–7.29 (2 m,
2 H), 6.49–6.56 and 6.56–6.63 (2 m, 1 H), 2.86 and 2.91 (2 s, 6 H)
1
solid (m.p. 81 °C). H NMR [400 MHz, CDCl3, two sets of signals
for (E) and (Z) isomers]: δ = 7.96–8.11 (m, 2 H), 7.67–7.82 (m, 2
H), 7.15–7.48 (m, 5 H), 6.66–6.78 (m, 2 H), 6.52–6.60 (m, 2 H),
ppm. 13C NMR [101 MHz, CDCl3, two sets of signals for (E) and 4.36–4.47 (m, 2 H), 2.895 and 2.905 (2 s, 6 H), 1.38–1.47 (m, 3 H)
(Z) isomers]: δ = 165.7 and 165.8, 147.4, 140.8, 140.7, 140.6, 138.0,
137.3, 134.9, 134.3, 132.9, 132.8, 130.1, 129.9, 129.7, 129.3, 129.2,
128.9, 128.3, 128.2, 128.1, 127.8, 127.7, 127.6, 127.1, 127.0, 126.6,
126.2, 126.1, 125.6, 123.3 and 123.4, 112.6 and 112.7, 40.7 and
40.8 ppm. C25H22N2 (350.46): calcd. C 85.68, H 6.33, N 7.99; found
C 85.52, H 6.13, N 7.96. MS (70 eV): m/z (%) = 352 (36), 351 (100),
ppm. 13C NMR [101 MHz, CDCl3, two sets of signals for (E) and
(Z) isomers]: δ = 166.2 and 166.3, 164.5 and 164.9, 147.5 and 147.7
142.0, 140.2, 140.1, 139.9, 136.9, 131.4, 130.3, 130.1, 129.6, 129.4,
129.3, 129.2, 128.84, 128.82, 128.5, 128.3, 128.2, 123.1 and 123.5,
112.4 and 112.6, 61.05 and 61.09, 40.67 and 40.70, 14.3 ppm.
C24H24N2O2 (372.47): calcd. C 77.39, H 6.49, N 7.52; found C
349 (13) [M]+, 274 (19), 224 (16), 208 (15), 136 (30), 77 (20). IR 77.37, H 6.48, N 7.51. MS (70 eV): m/z (%) = 373 (35), 372 (100)
(KBr): ν = 1605 (m), 1507 (s), 1441 (m), 1347 (m), 1226 (m), 1180 [M]+, 344 (31), 299 (13), 223 (21), 135 (14), 77 (15). IR (KBr): ν =
˜
˜
2793 (w), 1719 (s), 1607 (m), 1507 (s), 1443 (m), 1272 (vs), 1228
(s), 1100 (vs), 1014 (m), 958 (m), 820 (s), 782 (m), 710 (s) cm–1.
(m), 1166 (w), 1116 (w), 1060 (w), 936 (w), 896 (w), 818 (vs), 750
(m), 704 (vs) cm–1.
6494
www.eurjoc.org
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2011, 6486–6501